Oral cyclosporine A in neonatal swines for transplantation studies

Immunopharmacology and Immunotoxicology

Volumn 37, Issue 1, 2015, Pages 19-25

  Pan, Hua ^a,b   Gazarian, Aram ^c   Buff, Samuel ^b   Solla, Federico ^d   Gagnieu, Marie Claude ^a   Leveneur, Olivia ^b   Watrelot Virieux, Dorothée ^b   Morisset, Stéphane ^e   Sobh, Mohamad ^e   Michallet, Marie Cécile ^f   Roger, Thierry ^b   Dubernard, Jean Michel ^a   Michallet, Mauricette ^e  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c CLINIQUE DU PARC   (France)

^d Lenval Teaching Medical Center   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f International Research Center on Infectious Diseases   (France)

Author keywords

Acute renal effects; Cyclosporine A; Newborn swine; Pharmacokinetics; Transplantation

Indexed keywords

CREATININE; CYCLOSPORIN A; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BONE BIOPSY; CREATININE BLOOD LEVEL; DRUG CLEARANCE; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYALINE DEGENERATION; IMMUNOSUPPRESSIVE TREATMENT; MAXIMUM PLASMA CONCENTRATION; MICROEMULSION; NEWBORN; NONHUMAN; OSTEOARTHRITIS; TRANSPLANTATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DOSE RESPONSE; DRUG EFFECTS; FEMALE; KIDNEY; MALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PIG; RANDOMIZATION; TRANSPLANTATION TOLERANCE;

SUIDAE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; AREA UNDER CURVE; BLOOD UREA NITROGEN; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; RANDOM ALLOCATION; SWINE; TRANSPLANTATION TOLERANCE;

EID: 84918801699     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2014.975818     Document Type: Article

References (46)

1. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004;4:553-564.
2. Brent L. The 50th anniversary of the discovery of immunologic tolerance. N Engl J Med 2003;349:1381-1383.
3. Ridge JP, Fuchs EJ, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996;271: 1723-1726.
4. Touraine JL, Sanhadji K. Transplantation tolerance induced in humans at the fetal or the neonatal stage. J Transplant 2011;2011: 760319.
5. Urschel S, Campbell PM, Meyer SR, et al. Absence of donorspecific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age? Am J Transplant 2010;10:149-156.
6. van der Windt DJ, Dons EM, Montoya CL, et al. T-lymphocyte homeostasis and function in infant baboons: implications for transplantation. Transpl Int 2012;25:218-228.
7. Guenther DA, Madsen JC. Advances in strategies for inducing central tolerance in organ allograft recipients. Pediatr Transplant 2005;9:277-281.
8. Schonland SO, Zimmer JK, Lopez-Benitez CM, et al. Homeostatic control of T-cell generation in neonates. Blood 2003;102: 1428-1434.
9. Hassan J, Reen DJ. T-cell function in the human newborn. Immunol Today 2000;21:107-108.
10. West LJ. B-cell tolerance following ABO-incompatible infant heart transplantation. Transplantation 2006;81:301-307.
11. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen-presenting cell function in human neonates. Clin Immunol 2006;121: 251-259.
12. Schelonka RL, Infante AJ. Neonatal immunology. Semin Perinatol 1998;22:2-14.
13. Kovarik J, Siegrist CA. Immunity in early life. Immunol Today 1998;19:150-152.
14. Chelvarajan RL, Collins SM, Doubinskaia IE, et al. Defective macrophage function in neonates and its impact on unresponsiveness of neonates to polysaccharide antigens. J Leukoc Biol 2004;75: 982-994.
15. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
16. Gazarian A, Abrahamyan DO. [Hand allograft in agenesic newborn: feasibility study]. Ann Chir Plast Esthet 2007;52: 451-458.
17. Washington KM, Zanoun RR, Cadogan KA, et al. Composite tissue allotransplantation for the reconstruction of congenital craniofacial defects. Transplant Proc 2009;41:523-527.
18. Rothkotter HJ, Sowa E, Pabst R. The pig as a model of developmental immunology. Hum Exp Toxicol 2002;21:533-536.
19. Solla F, Pan H, Watrelot D, et al. Composite tissue allotransplantation in newborns: a swine model. J Surg Res 2013;179:e235-e243.
20. Greco R, Benito J, Gonzalez M, et al. Lung transplantation from ventilated non-heart-beating donors: experimental study in a neonatal swine model. J Pediatr Surg 1999;34:360-366.
21. Wagner C, Beebe DS, Carr RJ, et al. Living related liver transplantation in infants and children: report of anesthetic care and early postoperative morbidity and mortality. J Clin Anesth 2000;12:454-459.
22. Cibulskyte D, Pedersen M, Hjelm-Poulsen J, et al. The pharmacokinetics and acute renal effects of oral microemulsion ciclosporin A in normal pigs. Int Immunopharmacol 2006;6:627-634.
23. Cibulskyte D, Pedersen M, Jakobsen P, et al. Pharmacokinetic characterization of a pig model of ciclosporin A nephrotoxicity following intravenous administration. Pharmacol Res 2007;56: 311-317.
24. Soucek P, Zuber R, Anzenbacherová E, et al. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol 2001;1:11.
25. Skaanild MT, Friis C. Characterization of the P450 system in Gottingen minipigs. Pharmacol Toxicol 1997;80:28-33.
26. Diehl KH, Hull R, Morton D, et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 2001;21:15-23.
27. Frey BM, Sieber M, Mettler D, et al. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition. Drug Metab Dispos 1988;16:285-289.
28. Melter M, Rodeck B, Kardorff R, et al. Pharmacokinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral. Transpl Int 1997;10: 419-425.
29. Jones PJ, Hrboticky N, Hahn P, Innis SM. Comparison of breastfeeding and formula feeding on intestinal and hepatic cholesterol metabolism in neonatal pigs. Am J Clin Nutr 1990;51:979-984.
30. Ericzon BG, Todo S, Lynch S, et al. Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc 1987;19: 1248-1249.
31. Harit D, Faridi MM, Aggarwal A, Sharma SB. Lipid profile of term infants on exclusive breastfeeding and mixed feeding: a comparative study. Eur J Clin Nutr 2008;62:203-209.
32. Hollanders B, Aude X, Girard-Globa A. Lipoproteins and apoproteins of fetal and newborn piglets. Biol Neonate 1985;47:270-279.
33. Ahlmen J, Sundberg A, Gustavsson A, Strömbom U. Decreased nephrotoxicity after the use of a microemulsion formulation of cyclosporine A compared to conventional solution. Transplant Proc 1995;27:3432-3433.
34. Jackson NM, Hsu CH, Visscher GE, et al. Alterations in renal structure and function in a rat model of cyclosporine nephrotoxicity. J Pharmacol Exp Ther 1987;242:749-756.
35. Bennett WM, Pulliam JP. Cyclosporine nephrotoxicity. Ann Intern Med 1983;99:851-854.
36. Laskow DA, Curtis JJ, Luke RG, et al. Cyclosporine-induced changes in glomerular filtration rate and urea excretion. Am J Med 1990;88:497-502.
37. Murray BM, Paller MS, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int 1985;28:767-774.
38. Barros EJ, Boim MA, Ajzen H, et al. Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity. Kidney Int 1987;32:19-25.
39. Curtis JJ, Luke RG, Dubovsky E, et al. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986;2: 477-479.
40. Myers BD, Newton L, Boshkos C, et al. Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988;46:694-703.
41. Dean SK, Scott H, Keogh GW, et al. Effect of immunosuppressive doses of cyclosporine on pancreatic beta cell function in pigs. Am J Vet Res 2002;63:1501-1506.
42. Yamada K, Mawulawde K, Menard MT, et al. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load. J Thorac Cardiovasc Surg 2000;119:709-719.
43. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004;77:514-521.
44. Starnes VA, Marshall SE, Lewiston NJ, et al. Heart-lung transplantation in infants, children, and adolescents. J Pediatr Surg 1991; 26:434-438.
45. Ganschow R, Venzke A, Grabhorn E, et al. Liver transplantation in infants: how much immunosuppression is needed? Transplant Proc 2002;34:1963.
46. Dapper F, Bauer J, Kroll J, et al. Clinical experience with heart transplantation in infants. Eur J Cardiothorac Surg 1998;14:1-5; discussion 5-6.